HEAD & NECK CANCER
Clinical trials for HEAD & NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD & NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug enters first human tests
Disease control Not yet recruitingThis is a very early study to find the safest dose of a new drug called 177Lu-INN805 for people with advanced solid tumors that haven't responded to standard treatments. It will enroll about 10 patients with cancers like head & neck, lung, breast, or sarcoma to test how the body …
Matched conditions: HEAD & NECK CANCER
Phase: EARLY_PHASE1 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Pill before the knife: new hope for head and neck cancer patients
Disease control Not yet recruitingThis study is testing if giving patients a short course of an oral chemotherapy pill called capecitabine before their cancer surgery can lead to better results. The goal is to shrink tumors faster, make surgery less complex, and improve long-term survival for people with newly di…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New cell therapy trial opens for Tough-to-Treat cancers
Disease control Not yet recruitingThis early-stage study is testing a new cell-based treatment called SL-28 in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find the safest and most effective dose and to check for side effects. Participants will receive the…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New hope for head & neck cancer patients who Can't take standard chemo
Disease control Not yet recruitingThis study is for people with high-risk head and neck cancer who have had surgery but cannot take the standard chemotherapy drug cisplatin. It will test if adding two newer drugs (nimotuzumab and bemcentinib) to standard radiation therapy after surgery is better at keeping the ca…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC